Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals

Alzheimer’s disease biomarkers are primarily evaluated through MRI, PET and CSF methods in order to diagnose and monitor disease. Recently, advances in the assessment of blood-based biomarkers have shown promise for simple, inexpensive, accessible and minimally invasive tools with diagnostic and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lussier, Firoza Z, Benedet, Andréa L, Therriault, Joseph, Pascoal, Tharick A, Tissot, Cécile, Chamoun, Mira, Mathotaarachchi, Sulantha, Savard, Melissa, Ashton, Nicholas J, Karikari, Thomas K, Rodriguez, Juan Lantero, Snellman, Anniina, Bezgin, Gleb, Kang, Min Su, Fernandez Arias, Jaime, Wang, Yi-Ting, Gauthier, Serge, Zetterberg, Henrik, Blennow, Kaj, Rosa-Neto, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088291/
https://www.ncbi.nlm.nih.gov/pubmed/33959711
http://dx.doi.org/10.1093/braincomms/fcab073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088291/
https://www.ncbi.nlm.nih.gov/pubmed/33959711
http://dx.doi.org/10.1093/braincomms/fcab073

Ejemplares similares